MedinCell receives $ 6.4 million from Unitaid to fight malaria

Based in Jacou, near Montpellier, and employing 130 people, MedinCell is a technological pharmaceutical company which is developing a portfolio of long-acting injectable products by combining active principles already marketed with its proprietary BEPO® technology. The latter makes it possible to control and guarantee the regular delivery at an optimal therapeutic dose of a drug for several days, weeks or months from the subcutaneous or local injection of a simple deposit of a few millimeters.

On March 26, biotech announces that it has signed a $ 6.4 million grant agreement over three years with Unitaid, an international organization investing in ways to prevent, diagnose and treat HIV, tuberculosis, malaria and l hepatitis C, especially to developing countries.

The purpose of this grant is to finance the formulation and preclinical activities of a 3-month active injectable of ivermectin, a drug used in the treatment of many types of parasitic infections, to neutralize the vector of malaria transmission *.

Significant epidemiological impact

Our goal is to neutralize anopheline mosquitoes, which carry and transmit the malaria parasite, after they have bitten treated populations, says Christophe Roberge, CTO at MedinCell. This will allow us to break the chain of transmission. A single injection of active ivermectin for 3 months will make it possible to remove some of the logistical barriers to the adoption of mass treatments, since it will not require regular renewal of the treatment campaigns typically linked to oral forms whose duration of effectiveness is too short. “

Initial in vivo tests were conducted in Burkina Faso by the IRD, the IRSS, CIRDES and MedinCell.

(…) Read more on La Tribune.fr “data-reactid =” 30 “> (…) Read more on La Tribune.fr

Bill Gates Foundation awards $ 19 million to MedinCell
MedinCell expands its laboratories and recruits 20 people
“data-reactid =” 32 “>
Bill Gates Foundation awards $ 19 million to MedinCell
MedinCell expands its laboratories and recruits 20 people